Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Previous Speakers

Anil Kaul

Anil Kaul

Oklahoma State University, USA USA

Benfang Lei

Benfang Lei

Montana State University, USA USA

Zelenkova Hana

Zelenkova Hana

DOST Svidník, Slovakia Slovakia

K C Santosh

K C Santosh

University of South Dakota, USA USA

Sara M Dann

Sara M Dann

University of Texas Medical Branch, USA USA

Elizabeth De Nardo

Elizabeth De Nardo

GOJO Industries Inc., USA USA

Saungi McCalla

Saungi McCalla

White Plains Hospital USA

Stef Stienstra

Stef Stienstra

Armed Forces of Netherlands Netherlands

Infection Control 2019

Infection Control 2019

Details of Infectious Diseases Conferences 2019 in USA:

With the grand success from the previous relevant annual International conferences, ConferenceSeries llc Ltd is organizing "Infectious Diseases: Control and Prevention" (Infection Control 2019) scheduled during May 17-18, 2019 in Philadelphia, USA. Infection Control 2019 brings together the global leaders in infection control and relevant fields to present their research at this exclusive scientific program.

Conference Seriesorganizes a conference series of 1000+ Global Events inclusive of 1000+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

The Infection Control conference hosting presentations from editors of eminent refereed journals, renowned and active investigators and decision makers in the field of infectious diseases, microbiology, immunology, infection control and prevention. Infection control 2019 Organizing Committee also invites young investigators at each and every career stage to submit abstracts reporting their latest scientific researches in oral and poster sessions.

Infection control is required to prevent the transmission of communicable diseases in all health care settings. Infection control demands a basic understanding of the epidemiology of diseases; risk factors that increase patient susceptibility to infection; and the practices, procedures and treatments that may result in infections. the risk of acquiring a healthcare-associated infection is related to the mode of transmission of the infectious agent (e.g. CRE, CDI, MRSA, SSI, etc.) and the type of patient-care activity or procedure being performed and the underlying patient's host defences.

When we look at the worldwide deaths due to Infectious Diseases the conference get significance on some diseases like Tetanus (500,000), measles (1 million), Malaria (2.1million), hepatitis b (1.1million), diarrhoea (3.1 million), tuberculosis (3.1 million), HIV/AIDS (1 million) and respiratory Infections (4.4 million).

Who should attend?

  • Microbiologists
  • Bacteriologists
  • Virologists
  • Parasitologists
  • Mycologists
  • Pathologists
  • Pharmacists
  • Epidemiologists
  • Health Care Professionals
  • Infectious Diseases Specialists
  • Infection Prevention and Infection Control Specialists

Why to attend?

With members from all over the world concentrated on learning about global trends on emerging infectious diseases and it promotes in therapeutic and diagnostic market, this is your finest chance to reach the largest accumulation of participants from the Infectious diseases community. This particular conference Infection Control conduct presentations, distributes information, conducts meetings with current and prospective scientists, make a splash with new drug developments, and receive name recollection at this 2 days event. World distinguished speakers, the most recent therapeutic and diagnostic techniques, developments of Novel technologies and therapeutic measures for infectious diseases prevention and treatment are the authentication marks of this conference.

Targeted Audience

  • Directors, Board Members, Presidents, Vice Presidents, Deans and Head of the Departments
  • Infectious Diseases Researchers, Scientists, Faculties, Students
  • Infectious Diseases Associations and Societies
  • Medical Colleges
  • Pharmaceutical Companies and Industries
  • Medical Devices Manufacturing Companies
  • Drug Manufacturing Companies and Industries
  • Laboratory Technicians and Diagnostic Companies
  • Business Entrepreneurs and Industrialists
  • Training Institutes
  • Software Developing Companies
  • Data Management Companies

For Scientific Sessions please go through the link:

http://infectioncontrol.conferenceseries.com/call-for-abstracts.php

For Abstract Submission please go through the link:

http://infectioncontrol.conferenceseries.com/abstract-submission.php

Sessions & Tracks

Sessions & Tracks

Session-1: Infection Treatment and Control

Contamination counteractive action and control is required to keep the transmission of Infectious Ailments in all social insurance frameworks. These maladies are typically caused by microscopic organisms or infections and can be spread by human to human contact, creature to human contact, human contact with a contaminated surface, airborne transmission through little beads of irresistible operators suspended noticeable all around lastly, by such regular vehicles as water or sustenance. Infection control and Counteractive action requests a fundamental comprehension of the study of disease transmission of maladies, chance factors that expansion quiet defencelessness to contamination, and the practices, methodology and medicines that may bring about diseases. Late systems have demonstrated that there is no illness that can't be dealt with.

Session-2: Emerging Infectious Diseases

An Infectious malady whose event has expanded in the previous years or a reason to increment is named as developing. These maladies incorporate new diseases, beforehand unrecognized contaminations and old contaminations returning because of antimicrobial protection, general medical problems and unhygienic conditions. Human irresistible specialists develop and seem assignable to connection of different propelled factors between the host and pathogen each determined by the prerequisite to secure the achievement of the species in dynamical situations. Adjustment by one accomplice to exploit new situations can commonly animate the inverse to change its highlights to require favourable position of the change. Methicillin-ResistantStaphylococcus aureus, Atomic Epidemiology, New or Rapid Diagnostics, Testing/Quality Assurance, Host and Microbial Genetics, Antibody Preventable Diseases, New Vaccines.

Session-3: Veterinary Infection Control

Infectious diseases of animals are a major hazard to earthly animal health and welfare and their effective control is necessary for agronomic health, for defending and procuring national and international food supplies and for mitigating rural poverty in developing countries. Some catastrophic livestock diseases are regional in many parts of the world and threats from old and new pathogens continue to rise, with changes to worldwide climate, agricultural approaches and anthropology presenting conditions that are especially supportive for the spread of arthropod-borne diseases into new geographical fields. Zoonotic or phonetic infections that are transmissible either directly or indirectly between animals and humans are on the increase and pose serious additional risks to human health and the recent pandemic status of new influenza A (H1N1) is a topical illustration of the challenge presented by zoonotic viruses. Veterinary scientists often collaborate with Epidemiologists.

Session-4: Influenza and Diagnostic Approaches

Early diagnosis of influenza viral infections are critical for rapid initiation of antiviral therapy to reduce influenza related morbidity and mortality both during seasonal epidemics and pandemics. Several different approaches are currently available for diagnosis of influenza infections in humans. These include viral isolation in cell culture, immunofluorescence assays, nucleic acid amplification tests, immune chromatography-based rapid diagnostic tests, etc. Newer diagnostic approaches are being developed to overcome the limitations associated with some of the conventional detection methods. The rapid flu swab test is a relatively fast and accurate method for diagnosing influenza.

Session-5: Vaccine Research & Development

Vaccine Development is an activity that focuses on a variety of technological initiatives and applied research, which enhance and promote improved systems and practices for vaccine safety. In the past year, the unprecedented Ebola disease outbreak galvanized research and industry response and as we continue to search for solutions, we must review the lessons learned in order to overcome the current challenges. Vaccines development is a long, complex process, often lasting 10-15 years and involving a combination of public and private involvement. The current system for developing, testing, and regulating vaccines developed during the 20th century as the groups involved standardized their procedures and regulations.

Session-6: HIV Prevention, Treatment and Cure

HIV/AIDS still remains one of the most critical health challenges in the face of the world. According to reports around 36.7 million people are living with HIV and an estimated 1.8 million new infections are recorded in year 2016. There are some certain ways through which HIV can spread from one person to another such as blood, semen, pre-seminal fluids, rectal fluids, vaginal fluids and breast milk. HIV transmission is only possible if these fluids come in contact with the mucous membrane or damaged tissue or are directly injected into the bloodstream. HIV can also transmit from a mother to her child during the time of pregnancy, childbirth or breastfeeding. Earlier, there were some cases of HIV transmission during organ or tissue transplant from a HIV infected person. HIV treatment involves taking medicines that are called antiretrovirals also known as ARV. These are always given in combination with other antiretrovirals. The therapy involved is called antiretroviral therapy also named as ART. Using ART drugs has significantly reduced the number of deaths related to AIDS.

Session-7:  Infectious Disease Pathology

Plant pathology (likewise phytopathology) is the logical investigation of sicknesses in plants caused by pathogens (irresistible creatures) and ecological conditions (physiological factors).Organisms that reason irresistible malady incorporate growths, oomycetes, microorganisms, infections, viroids, infection like life forms, phytoplasmas, protozoa, nematodes and parasitic plants. Excluded are ectoparasites like bugs, vertebrate, or different nuisances that influence plant wellbeing by utilization of plant tissues. Plant pathology additionally includes the investigation of pathogen recognizable proof, sickness etiology, ailment cycles, monetary effect, plant malady the study of disease transmission, plant ailment protection.

Session-8:  Nosocomial Infections & Control

These infections are acquired due to development of favourable conditions in hospital environment, infected by a patient during a hospital visit or one developing among hospital staff. The types of microorganisms cause nosocomial infections contribute about 99,000 deaths each year according to Centers for Disease Control and Prevention. Recent survey by hospitals reports, Gram-negative infections are estimated to account for two-thirds of the 25,000 deaths each year. Urinary tract infections, pneumonia, bloodstream, and other parts of the body are comes under these category. Most of the infections are difficult to attack with antibiotics, and Gram-negative bacteria resistant to antibiotic can infect people outside the hospital. The prevention and control of nosocomial infections sets new goals for the epidemiologists and infection control practitioners beyond the basics. 

Session-9:  Pediatric Infectious Diseases

Pediatrics is the field of medicine that is concerned about the well-being of neonatal, children, and adults. It also concerns on their development and advancement and their chance to accomplish maximum capacity as grown-ups. The Pediatric academy of America, prescribes that the children should be under pediatric care, up to the age of 21. The point of investigation of pediatrics is to decline the death rate of children and newborns, to control the spread of infectious diseases, for a long ailment free life.  Infectious diseases, which annually claim about 14 million lives i.e. 25% of the more or less 56 million deaths recorded worldwide. The recent trends of pediatrics have achieved exceptional advances in reductions in childhood mortality. The global challenge of preventing HBV in children has shown that the deadliest infectious diseases can be prevented by acquiring proper awareness.

Session-10:  Infection Control Bacteriology

Bacteriology and Infectious Diseases rely upon examination of Bacterial Ecology, Bacterial Infection, Pathogenic Bacteria, Bacterial toxins, Bacterial genomics, Salmonella, Bacterial Diseases, immunology, bacteriology, mycology, virology, parasitology, Parasitic Worms, Anthrax, Biological weapons, Leprosy, pathology, and pathophysiology of the causative specialists of infectious diseases. It likewise serve to give bits of knowledge into until now unexplored domains of clinical microbiology and infectious diseases, for example, improvement of multi-medicate protection (MDR), advancement of novel antibodies and anti-toxins to neutralize the impacts of MDR, variety of contamination and illness dissemination mapping. It also provides novel discoveries on the ecology, biochemistry and genetics of pathogenic bacteria, viruses, fungus and other infectious parasites. Contemporary findings pertaining to the development of highly advanced diagnostic and therapeutic methods against infectious diseases viz. malaria, influenza, tuberculosis, leprosy, whooping cough, polio, Hepatitis-A, HIV/AIDS.

Session-11: Disinfection and Sterilization

Disinfection and Sterilization are the most common decontamination process, where the disinfection is used to eliminate or reduces the harmful pathogens from the objects or surfaces, and sterilization is process of killing the microbes, spores and harmful pathogens. Disinfectant types includes, air disinfectants, alcohols, aldehydes, oxidizing agents, and phenolic are used to decontaminate the surfaces and, sterilizations types includes steam, heat, chemical sterilization, radiation sterilization, and sterile filtration are used for food, medicine and surgical instruments. Most of adherence to strict recommendation of these methods can reduce the infections associated with contaminated items of patients or food processing. 

Session-12:  Nursing Infection Control

Contamination control nurture is a medical caretaker that spends significant time in keeping the spread of irresistible specialists, for example, infections and microscopic organisms. As contamination control nurture, you will take part in counteracting risky flare-ups and pestilences. Contamination control medical attendants ought to show a great tender loving care and powerful relational abilities. They will frequently need to perform obligations, for example, showing others how to avert and contain episodes and plagues and also work with government organizations to contain these occurrences. The essential obligation of contamination control medical attendants is to keep the spread of irresistible operators. To do this, these attendants will frequently need to teach other therapeutic experts and regular citizens on contamination aversion procedures. This may incorporate advising others about how certain irresistible specialist spread, alongside how to shield themselves as well as other people from defilement.

Session-13:  Hepatitis Prevention

The greater part as a relatable point routes from claiming transmission for hepatitis infections are blood transfusions also blood results utilizing unscreened blood (in the vast majority created nations blood need been screened since regarding 1990). Medicinal or dental intercessions without sufficient disinfection for supplies. Mothball will, hepatitis C). Needle stick harm done social insurance settings. Imparting gear for injecting baby throughout labour (very basic for hepatitis B; Lesquerella as a relatable point previously pills. Offering razors, toothbrushes alternately other family articles. Tattooing also muscle to piercing if finished utilizing unsterilized supplies. On account from claiming hepatitis B, contamination camwood also happen through hosting unprotected sex for a contaminated man. Though you believe you might need been toward danger starting with possibly hepatitis B or C, it may be essential on get tried. A particular test may be needed to every.

Session-14:  Infection Control in Dental

Dentistry touches every part of our lives, however, is usually underestimated. Your mouth is a window to the strength of your body. It can lead to deficiencies or general oral diseases. Despite whether you are 80 or 8, your oral prosperity is important. Diseases that affect the entire body, may first start up normally and will be unnoticed because of mouth wounds or other oral issues. Presently patients can make use of the advances in  Clinical dentistry and dental practices can benefit by the opportunity to propel  their business a forward way. Infections in oral health care settings can be controlled by following the procedures and precautions are taken to prevent spreading of infectious diseases.  According to the Centers for Disease Control and Prevention, special recommendations need to be followed in dental offices including, cleaned and decontaminated surfaces, cleaned and sterilized dental items must be used in between patients, usage of appropriate protective garb (gloves, gowns, masks, and eyewear) and, most of the transmission of infectious diseases such hepatitis B, hepatitis C, and HIV can be controlled in the dental offices.

Session-15:  Treatment for Tuberculosis

Tuberculosis is a bacterial infection caused by a bacterium called mycobacterium tuberculosis which spread through the lymph nodes and blood stream to any organ in your body. It is most commonly found in the lungs which attack the lungs and it can also attack any part of the body such as the kidney, spine and brain. Tuberculosis is a deadly infectious disease caused by mycobacterium tuberculosis and it is transmitted through air via droplets through cough and sneeze. Most of the infections do not have symptoms and this condition is called as latent tuberculosis which should be treated immediately otherwise it leads to death. Tuberculosis mainly affects lungs and other parts of the body as well.

Session-16:  Risk Factors & Prevention

The patient risk factors depend on the direct relationship between the age and susceptibility towards infections.  Mostly these factors can be seen due to impaired immune function, anatomic, functional changes, and amount of exposure towards infection results in the elder patients reduces the quality of life during the infection and conditions are fatal. The range of serious risk factors commonly seen in elder patients with respiratory infections, hospital acquired infections or nosocomial infections, also the other factors particular cited in the patients with urinary tract infections, hepatitis and salmonellosis.

Session-17:  Infection Control Treatment & Diagnosis

Treatment of viral infections such as HIV involves patient care and moral support including antiretroviral therapy. Bacterial infections can be treated by administering antibiotics to the patients. Yeast infections can be primarily treated by sterilisation methods. Parasitic infections can be treated by antiparasitic drugs. Diseases such as cancer can be treated by chemotherapy. Recent techniques have proved that there is no disease that cannot be treated. Medical diagnosis is the process of determining which disease or condition explains a person's symptoms and signs. Laboratory tests may identify organisms directly (e.g., visually, using a microscope growing the organism in culture) or indirectly (e.g., identifying antibodies to the organism). General types of tests include microscopy, culture and immunologic tests (agglutination tests such as latex agglutination, enzyme immunoassays, western blot, precipitation tests and complement fixation tests) and nucleic acid/ non nucleic acid based identification methods. Sub types of diagnoses include clinical, laboratory, radiology, principal and admitting diagnosis. Advanced methods have been implemented to diagnose the infection in any part of the body. Examples include biomarkers/ elisa test/ chest x ray/ skin biopsy/ tympanometry and tympanocentesis.

Session-18:  Practices & Awareness

Public awareness refers to the important role that community knowledge and enthusiasm has in building manageable societies. Delivering knowledge to remote communities requires strategies for effective communication regarding infections treatment and control and maintenance of good hygienic conditions by creating healthy environment and infection free world. The growing aging population, with associated rise in the incidence of chronic diseases have also led to an increased demand of infection control products. However, factors such as stringent regulatory requirements and the need to comply with them may restrain the growth of infection control market to a certain extent.

Session-19:  Infection Control Precautions

Infection control precautions are a set of standard recommendations for designed to reduce the risk of transmission of infectious agents from body fluids or environmental surfaces that contain infectious agents. Infection prevention and control uses a risk management approach to minimise or prevent the transmission of infection. The two-tiered approach of standard and transmission-based precautions provides a high level of protection to patients, healthcare workers and other people in healthcare settings. The use of standard precautions aims to minimise, and where possible, eliminate the risk of transmission of infection, particularly those caused by blood borne viruses.

Session-20: Practical Guidelines

One of the prime effective ways in which we've got to protect ourselves from ill health is  personal hygiene. This suggests wash your hands especially, however additionally your body. It means that being careful to not cough or sneeze on others, cleansing things that you simply bit if you're unwell, golf stroke things like tissues into a bin, associate degree victimisation protection after you may be in danger of catching an infection. People should know about guidelines and recommendations related to infection prevention. HAIs are currently one of the top ten leading causes of death in the United States. Healthcare professionals have an important role in HAI prevention. Infection control measures are a set of standard recommendations that can be used to reduce the risk of transmission of infectious agents from body fluids that contain infectious agents.

Session-21: Infection Control Business

Any discussion of the business case for infection control (IC) must start by acknowledging that the single most important reason for IC is to prevent morbidity and mortality associated with nosocomial infections. Each year, hundreds and thousands of Americans suffer the consequences of nosocomial infections which can be ranging from the inconvenience of taking extra medications to death. Beyond the human cost is the important economic burden that these infections place on society, including not only the obvious increase in health care resource use but also indirect costs associated with the loss of productivity of patients and their caregivers.

------------------------------------------------------------------------------------------------------------------------------------------

Related Conferences:

4th Annual Congress on Infectious Diseases, August 29-30, 2018 Boston, USA, 5th Annual Congress on Rare diseases and Orphan Drugs, August 29-30, 2018 Boston, USA, 5th International Conference on Neglected Tropical & Infectious Diseases, August 29-30, 2018 Boston, USA, 3rd International Conference on Flu and Emerging Infectious Disease: Control & Prevention, November 07-08, 2018 Alabama, USA, 7th International Conference and exhibition on Bacteriology & Antibiotics, April 24-25, 2019 Vancouver, Canada

11th International Conference on Rare Diseases and Orphan Drugs (ICORD), September 13-16, 2018   Johannesburg, South Africa;  Orphan Drugs Summit, September 2018, The Netherlands; SMi's 7th annual Orphan Drugs and Rare Diseases UK Conference, 18–19 October 2017 London, United Kingdom

Related Societies:                  

USA: AIDS Healthcare Foundation, Centre for AIDS Research, Northland Cares, Arizona, The McGregor Clinic, Inc., Canadian Public Health Association, Tropical Pathology & Infectious Diseases Associations, International Society for Infectious Diseases, AIDS United, HIV.gov, AmfAR, UNAIDS, The Elizabeth Taylor AIDS Foundation, International AIDS Society, International HIV/AIDS Alliance, Addiction Research and Treatment Corporation, AIDS Community Research Initiative of America, Albert Einstein College of Medicine, Community Healthcare Network, Elmhurst Hospital Center, Evergreen AIDS Foundation, Lifelong AIDS Alliance

EuropeEuropean Society for Clinical Microbiology and Infectious Diseases,  British Society for Antimicrobial ChemotherapySociety for General Microbiology

Asia PacificHuman Genetics Society of AustralasiaGenetics Society of JapanNDC Medicine.

Market Analysis

Importance and Scope

The market is projected to reach USD 33.78 billion by 2021 and is growing at a CAGR of 8.3% during the forecast period which is from 2016 to 2021. Hospital acquired infections are also called as nosocomial infections and that are acquired in hospitals and other healthcare facilities. These infections can occur up to 48 hours after hospital admission or up to 3 days after discharge or up to 30 days after an operation or in a healthcare facility, when the patient was admitted for reasons other than infection.

The global hospital acquired infection control market is categorized which is on the basis of Pathogen Types (Viral, Bacterial, and Fungal), Treatment (Air, Water, Physical Surfaces, Skin Disinfectants, and Sterilization), Infection Type (Urinary Tract Infections, Blood Stream Infections, Surgical Site Infections, Hospital Acquired Pneumonia, Gastrointestinal Infections, and Tuberculosis), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

Conferenceseries welcomes all the specialists and super specialists, research scholars, industrial professionals and student delegates from biomedical and healthcare sectors to be a part of the esteemed Infection Control-2019. It also catalyses for information exchange and networking between researchers and business entrepreneurs of diverse backgrounds for the advancement of Technology and Research in the field of Infection Control. As this will be the best amalgamation of academia and research involving every aspect of empirical and conceptual thinking in exploring new dimensions in this field. It is open to all types of research methodologies both from academia and industry.

Why Philadelphia?
   Philadelphia is the largest city in the Commonwealth of Pennsylvania and the 6th most crowded city in the United States, with an expected populace of 1,567,872 and more than 6 million in the seventh-biggest metropolitan measurable zone, starting at 2016.Philadelphia is the financial and social stay of the Delaware Valley—a district situated in the Northeastern United States at the intersection of the Delaware and Schuylkill Rivers with 7.2 million individuals dwelling in the eighth-biggest joined factual region in the United States.

The Philadelphia territory's numerous colleges and schools make it a best report goal, as the city has advanced into an instructive and monetary center point. With a GDP of $388 billion, Philadelphia positions ninth among world urban communities and fourth in the country. Philadelphia is the focal point of financial action in Pennsylvania and is home to five Fortune 1000 organizations. The Philadelphia horizon is developing, with a market of just about 81,900 business properties in 2016 including a few broadly unmistakable high rises. The city is known for its specialties, culture, and rich history, drawing in more than 41 million local sightseers alone in 2015. Philadelphia has more open air figures and paintings than some other American city. Fairmount Park, when joined with the nearby Wissahickon Valley Park in a similar watershed, is one of the biggest coterminous urban stop ranges in the United States. The 67 National Historic Landmarks in the city helped represent the $10 billion produced by tourism. Philadelphia is the origination of the United States Marine Corps and is likewise the home of numerous U.S. firsts, including the primary library (1731) first healing facility (1751) and medicinal school (1765), first Capital (1777), first stock trade (1790), first zoo (1874) and first business college (1881).Philadelphia is the main World Heritage City in the United States.

Conference Highlights

·         Infection Treatment and Control

·         Emerging Infectious Diseases

·         Infection Novel Therapies

·         Treatment & Diagnosis

·         Healthcare-Associated Infection (HAIs)

·         HIV/AIDS from STDs & STIs

·         Infection by Zoonoses

·         Disinfection/Sterilization

·         Infections from Plants

·         Multidrug-Resistant Microorganisms

·         Infections During Pregnancy

·         Pediatric Infectious Diseases

·         Practices and Awareness

·         Multi Pathogen Infections

·         Practical Guidelines

·         Infection Control Business

Why to attend?

With members from around the world focused on learning about global trends on emerging infectious diseases and its advances in therapeutic and diagnostic market, this is your best opportunity to reach the largest assemblage of participants from the Infectious diseases community. This particular conference conduct presentations, distributes information, conducts meetings with current and potential scientists, make a splash with new drug developments, and receive name recognition at this 3 days event. World renowned speakers, the most recent therapeutic and diagnostic techniques, developments, and the Novel technologies and therapeutic measures for infectious diseases prevention and control are hallmarks of this conference.

Statistics of Researchers, Academicians and Industrial

·         International Federation of Infection Control (IFIC)

·         Association for Professionals in Infection Control and Epidemiology(APIC)

·         Infection Prevention Society (IPS)

·         American Journal of Infection Control(AJIC) 

·         Centers for Disease Control and Prevention(CDC)

·         Infectious Disease Society of America (IDSA)

·         Infectious Diseases Research Network (IDRN)

·         Australasian College for Infection Prevention and Control (ACIPC)

·         European Society for Clinical Microbiology and Infectious Diseases (ESCMID)

·         British Infection Association(BNA)

·         The Hospital Infection Society (HIS)

·         Infection Prevention Society (IPS)

·         World Health Organization (WHO) 

·         American Nurses Association(ANA)

·         Nigerian Infection Control Association (NICA) 

·         Infection Control Society of Southern Africa(ICSSA)

·         Washington State Hospital Association (WSHA)

Top Universities Worldwide

·         The University of British Columbia, Canada

·         American Sentinel University, USA

·         University of Toronto, Canada

·         University of South Florida,USA

·         Drexel University,USA

·         Griffith University,AUSTRALIA

·         Columbia University,USA

·         King's College London, University of London,UK

·         University of Dundee, Uk

·         University of Oxford,Uk

·         University of Cambridge,UK

·         Western University (Ontario), Canada

·         University of Otago, NEW ZEALAND

·         Imperial College London,UK

·         UCL (University College London),UK

·         Toi-Ohomai Institute of Technology, NEW ZEALAND

·         The University of Sydney, AUSTRALIA

·         Keele University, UK

Infection Control Therapeutic Market

The global market for infectious disease treatments was valued at $90.4 billion in 2009. This market is expected to increase at a compound annual growth rate (CAGR) of 8.8% to reach $138 billion in 2014. The largest market share belongs to antibiotic treatments for bacterial and fungal diseases at 53% of the total infectious disease treatment market.  Fungal disease treatments will experience a slightly higher compound annual growth rate (CAGR) of 6.2%, from $4.6 billion in 2009 to $6.2 billion in 2014. Viral disease treatments will have the fastest compound annual growth rate (CAGR) of 12.1%, increasing from nearly $45 billion in 2009 to $79 billion in 2014.

Infection Control Market worth 17.78 Billion USD by 2021

The infectious diseases therapeutic market in US is estimated to grow at a rate of 3.37% between 2014- 2019. As per the records, 25% of deaths are mainly due to infectious diseases globally. Current market trend shows that North America. America highest global market is expected in Asia then followed by the Europe in the global infectious diseases therapeutics market. 

The main reasons behind the highest global market of infectious diseases therapeutics market in the above countries is mainly due to large number of patients and due to increase in government funding. Market for infectious disease molecular diagnostics tests includes hospitals, blood banks, reference laboratories.

The report "Infection Control Market by Disinfection (Disinfectant, Disinfectors, Endoscope Reprocessors, Wipes, Face Masks) Sterilization (Steam Sterilization, Ethylene Oxide, VHP, E-beam, Contract Services) End User (Hospitals, Lifescience) - Global Forecast to 2021", analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa in the coming years

 

The rise in the incidences of different types of hospital acquired infections, innovative technologies implemented in devices that control infection, awareness regarding the use of personalized medicines, and cost-effective drugs to treat hospital acquired infections are some of the factors that are driving the growth of this market.

However, the lack of awareness regarding hospital acquired infection and increased usage of outpatient treatment are hampering the growth of this market.

 

Past Conference Report

Infection Control 2018

Infection Control 2018 Past Conference Report

Sensing the raising importance of Infectious Diseases prevention, control, treatment and cure, Conference Series LLC Ltd hosted 3rd International Conference on Infection, Disease Control  and Prevention(Infection Control 2018), scheduled from June 25-26, 2018 in Vancouver, Canada with a theme “To Safeguard Public Health”.  The conference was successful in gathering eminent speakers from various reputed organizations and their paramount talks enlightened the gathering.

The pragmatic meet organized by Conference Series LLC Ltd received generous response from the Editorial Board Members of Conference Series LLC Ltd Journals as well as expertise from academia, talented researchers and young student community. Researchers and students who attended from different parts of the world made the conference one of the most successful and productive events in 2018 from Conference Series LLC Ltd. The conference was marked with the presence of renowned Speakers, Young Researchers, Students and Business Delegates driving the three day event into the path of success with thought provoking keynote and plenary presentations.

The meeting was carried out through various sessions, in which the discussions were held on the following thought provoking and cerebrating scientific tracks:

Infection Control 2018 Proceedings

  • Key Note Forum
  • Tracks
  • Posters and Accepted Abstracts

The conference was embarked with an opening ceremony followed by Keynote presentations, Workshop and a series of lectures delivered by both Honourable Guests and members of the Keynote forum. The adepts who promulgated the theme with their exquisite talk were:

1. Moderators

  • Dr. Hana Zelenkova, DOST Svidnik, Slovakia

2. Session Chairs

3. Keynote Presentations

Conference Series LLC Ltd offers its heartfelt appreciation to Societies and Organizations, Organizing Committee Members, adepts of field, various outside experts, company representatives and other eminent personalities who interlaced with Conference Series LLC Ltd in supporting and making the conference a grandiose event.

Your rejoinder is our inspiration, keeping this motto in mind and being witnessed the triumph of Infection Control  2018Conference Series LLC Ltd is delighted to announce the next event, "4th  International Conference on Infection Control" to be held during May 17-18, 2019, Philadelphia, USA.

Contact us for more queries…!!!!

Infection Control 2019

Catherine Taylor

[email protected]

702-508-5200

Let us meet again Infection Control 2019


Past Reports  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date May 17-18, 2019

For Sponsors & Exhibitors

[email protected]

Speaker Opportunity

Past Conference Report

Supported By

Journal of Infectious Diseases and Therapy

Air and Water Borne Diseases

Journal of Immunological Techniques in Infectious Diseases

Journal of Bacteriology and Parasitology

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by


Keytopics

  • Adenovirus Infections
  • Air-Borne Infections
  • Amoebiasis
  • Antenatal Screening
  • Anthrax
  • Antibiotic Use
  • Antimicrobial Resistance
  • Automated Surveillance
  • Avian Influenza
  • Bacillus Anthracis
  • Bacterial Infections
  • Blood-Borne Infections
  • Borreliosis
  • Botulism
  • Bovine Spongiform Encephalopathy - BSE
  • Burkholderia Pseudomallei
  • Campylobacteriosis
  • Catheter-Associated Urinary Tract Infection
  • Chagas Disease (American Trypanosomiasis)
  • Chikungunya Virus
  • Chlamydiosis
  • Cholera
  • Clostridium Difficile
  • Conjunctivitis
  • Control And Prevention Of Infections
  • Corynebacterium Infection
  • Cowpox
  • Coxsackievirus
  • Crimean-Congo Haemorrhagic Fever - CCHF
  • Cryptosporidiosis
  • Cyclosporiasis
  • Cytomegalovirus (Cme) Infection
  • Dengue Virus
  • Diphtheria
  • Diseases, Syndromes, Conditions
  • Ebola Virus
  • Echovirus
  • Emerging Or Re-Emerging Diseases
  • Encephalitis
  • Entamoeba Hystolitica
  • Enterohaemorrhagic E. Coli - Ehec
  • Epidemiology
  • Erythema Infectiosum (Fifth Disease)
  • Escherichia Coli
  • Evidence-Based Medicine
  • Flaviviridae
  • Food-Borne Infections
  • Fungal Infections
  • Gastrointestinal Disease
  • Giardia
  • Giardiasis
  • Gonorrhoea
  • Haemolytic Uraemic Syndrome
  • Haemophilus Influenzae
  • Haemophilus Influenzae Infection
  • Haemorrhagic Fever
  • Hantavirus Infections
  • Hepatitis
  • Human Papillomavirus Infection
  • Infection After Hysterectomy
  • Infection Control Nursing
  • Influenza
  • Influenza Virus
  • Invasive Pneumococcal Disease
  • Laboratory Surveillance
  • Legionellosis
  • Legionnaires' Disease
  • Listeriosis
  • Lyssaviruses
  • Medical Asepsis
  • Norovirus
  • Norovirus Infection
  • Parasitic Diseases
  • Phleboviruses
  • Poliovirus
  • Poxvirus
  • Protozoal Infections
  • Q Fever
  • Rabies
  • Respiratory Viruses
  • Rickettsia
  • Rift Valley Fever
  • Rotavirus Infection
  • Salmonella
  • Sexually Transmitted Infections
  • Standard Precautions
  • Staphylococcus Aureus
  • Toscana Virus
  • Transmission-Based Precautions
  • Tuberculosis
  • Tularaemia
  • Vaccine-Preventable Diseases
  • Vaccines And Immunisation
  • Variant Creutzfeld-Jakob Disease
  • Varicella Virus Infection (Chickenpox)
  • Vector-Borne Infections
  • Ventilator-Associated Pneumonia
  • Yellow Fever
  • Yersiniosis
  • Zoonoses